Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The National Institute of Health (NIH) has awarded a Specialized Program of Research Excellence (SPORE) in Ovarian Cancer to MD Anderson Cancer Center, Houston Texas. 

The value of the award is $8.7 Million over 5 years. Congratulations to Professor Ahmed who is a co-investigator on one of three programs that are supported by this prestigious award. The program aims to test the therapeutic value of SIK2 inhibitors in ovarian cancer patients. 

Our research at the Nuffield Department of Obstetrics & Gynaecology explores the molecular mechanisms that drive Ovarian Cancer cell growth and examines which targeted therapies can be utilised to improve the treatment of women with Ovarian Cancer.

Read more about our research on Ovarian Cancer 

Ahmed Ahmed

Our Research Groups